跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRZ-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRZ-TADALAFIL
Authorized
STANDARD
PRZ-TADALAFIL
pharmaris canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c6d0925196305915
Company
pharmaris canada inc
Type
Standard
Approval Details
Approval Id
c6d0925196305915
Drug Approval Canada Name
PRZ-TADALAFIL
Product Name
PRZ-TADALAFIL
Status
Marketed
Status Date
2021-09-27
Original Market Date
2021-09-27
Din
02512270
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Atc Name
g 04 be 08
Aig Number
0149485004
Company Name
pharmaris canada inc
Company Address
102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9
Active Ingredients
TADALAFIL
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c6d0925196305915
Type
Standard
Back to Health Canada Approvals